Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
maurizio.inghilleri@uniroma1.it
Maurizio Inghilleri
Professore Associato
Struttura:
DIPARTIMENTO DI NEUROSCIENZE UMANE
E-mail:
maurizio.inghilleri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country
GENES
2021
Progressione della disfagia orofaringea nella sclerosi laterale amiotrofica: studio retrospettivo longitudinale.
abstract SIOeChF 2021
2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
LANCET NEUROLOGY
2021
Progression of oropharyngeal dysphagia in amyotrophic lateral sclerosis: a retrospective cohort study
DYSPHAGIA
2021
Bradykinesia in motoneuron diseases
CLINICAL NEUROPHYSIOLOGY
2021
PREVALENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN LATIUM REGION (ITALY)
BRAIN AND BEHAVIOR
2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
NATURE GENETICS
2021
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients
NEUROLOGICAL SCIENCES
2021
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
MUSCLE & NERVE
2021
Progressione della disfagia orofaringea nella sclerosi laterale amiotrofica: studio retrospettivo longitudinale
Congresso SIAF 2021
2021
Isolated Bilateral Tapia’s syndrome after several oro-tracheal intubations: anatomical and pathophysiological considerations
FUNCTIONAL NEUROLOGY
2020
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
2020
Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis
NATURE COMMUNICATIONS
2020
Creatine kinase and progression rate in amyotrophic lateral sclerosis
CELLS
2020
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab
JOURNAL OF NEUROLOGY
2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
2020
Nerve high resolution ultrasonography in Tangier disease
MUSCLE & NERVE
2019
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study
SCIENTIFIC REPORTS
2019
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.
CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS
2019
Italian recommendations for the diagnosis and treatment of myasthenia gravis
NEUROLOGICAL SCIENCES
2019
« prima
< precedente
1
2
3
4
5
6
seguente ›
ultima »
Gruppi di ricerca - Responsabile
Gruppo di ricerca sulla sclerosi laterale amiotrofica
Gruppo di ricerca sull'amiloidosi sistemica da transtiretina
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma